{"altmetric_id":3629974,"counts":{"readers":{"mendeley":5,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:30541005"],"posts_count":1}},"citation":{"ads_id":"1999NYASA.890...42M","altmetric_jid":"4f6fa51b3cf058f6100038d2","authors":["MERCHANT, RANDALL E.","BULLOCK, M. ROSS","CARMACK, CYNTHIA A.","SHAH, AJIT K.","WILNER, KEITH D.","KO, GRANT","WILLIAMS, STEPHEN A."],"doi":"10.1111\/j.1749-6632.1999.tb07979.x","first_seen_on":"2015-02-14T18:40:40+00:00","issns":["1749-6632"],"journal":"Annals of the New York Academy of Sciences","last_mentioned_on":1295502568,"links":["http:\/\/dx.doi.org\/10.1111\/j.1749-6632.1999.tb07979.x"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.1999.tb07979.x\/pdf","pubdate":"2006-02-06T00:00:00+00:00","publisher":"Blackwell Publishing Ltd","publisher_subjects":[{"name":"Multidisciplinary","scheme":"era"}],"scopus_subjects":["Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["science"],"title":"A Double\u2010Blind, Placebo\u2010Controlled Study of the Safety, Tolerability and Pharmacokinetics of CP\u2010101,606 in Patients with a Mild or Moderate Traumatic Brain Injury","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/doubleblind-placebocontrolled-study-safety-tolerability-pharmacokinetics-cp101606-patients-mild-mode-4"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3615908,"mean":4.932414788326,"rank":815317,"this_scored_higher_than_pct":62,"this_scored_higher_than":2276896,"rank_type":"exact","sample_size":3615908,"percentile":62},"similar_age_3m":{"total_number_of_other_articles":93868,"mean":7.2186410772689,"rank":23857,"this_scored_higher_than_pct":73,"this_scored_higher_than":68935,"rank_type":"exact","sample_size":93868,"percentile":73},"this_journal":{"total_number_of_other_articles":2803,"mean":3.5337416131335,"rank":519,"this_scored_higher_than_pct":45,"this_scored_higher_than":1280,"rank_type":"exact","sample_size":2803,"percentile":45},"similar_age_this_journal_3m":{"total_number_of_other_articles":40,"mean":2.5589743589744,"rank":7,"this_scored_higher_than_pct":82,"this_scored_higher_than":33,"rank_type":"exact","sample_size":40,"percentile":82}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":2,"Student  > Ph. D. Student":2},"by_discipline":{"Neuroscience":1,"Agricultural and Biological Sciences":4}}},"geo":{"mendeley":{"US":1}}},"posts":{"wikipedia":[{"title":"Traxoprodil","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=408923519#altmetric_citation_6","license":"public","citation_ids":[3629974,3629976],"posted_on":"2011-01-20T05:49:28+00:00","summary":"Traxoprodil (CP-101,606) is a drug developed by Pfizer which acts as an NMDA antagonist, selective for the NR2B subunit.","page_url":"http:\/\/en.wikipedia.org\/?curid=30541005","wiki_lang":"en","author":{"name":"Meodipt","url":"http:\/\/en.wikipedia.org\/wiki\/User:Meodipt"}}]}}